Scaffolding by ERK3 Regulates MK5 in Development

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 2004 Nov 13

PMID 15538386

Citations 59

Authors

Stefanie Schumacher

Kathrin Laass

Shashi Kant

Yu Shi

Axel Visel

Achim D Gruber

Alexey Kotlyarov

Matthias Gaestel

Affiliations

Soon will be listed here.

Abstract

Extracellular-regulated kinase 3 (ERK3, MAPK6) is an atypical member of the ERKs, lacking the threonine and tyrosine residues in the activation loop, carrying a unique C-terminal extension and being mainly regulated by its own protein stability and/or by autophosphorylation. Here we show that ERK3 specifically interacts with the MAPK-activated protein kinase 5 (MK5 or PRAK) in vitro and in vivo. Expression of ERK3 in mammalian cells leads to nuclear-cytoplasmic translocation and activation of MK5 and to phosphorylation of both ERK3 and MK5. Remarkably, activation of MK5 is independent of ERK3 enzymatic activity, but depends on its own catalytic activity as well as on a region in the C-terminal extension of ERK3. In mouse embryonic development, mRNA expression patterns of ERK3 and MK5 suggest spatiotemporal coexpression of both kinases. Deletion of MK5 leads to strong reduction of ERK3 protein levels and embryonic lethality at about stage E11, where ERK3 expression in wild-type mice is maximum, indicating a role of this signalling module in development.

Citing Articles

ERK3 is involved in regulating cardiac fibroblast function.

Sahadevan P, Dingar D, Nawaito S, Nair R, Trepanier J, Sahmi F Physiol Rep. 2024; 12(11):e16108.

PMID: 38872461 PMC: 11176743. DOI: 10.14814/phy2.16108.

Role of the Atypical MAPK ERK3 in Cancer Growth and Progression.

Elkhadragy L, Myers A, Long W Cancers (Basel). 2024; 16(7).

PMID: 38611058 PMC: 11011113. DOI: 10.3390/cancers16071381.

Emerging roles of deubiquitinating enzymes in actin cytoskeleton and tumor metastasis.

Xue Y, Xue C, Song W Cell Oncol (Dordr). 2024; 47(4):1071-1089.

PMID: 38324230 DOI: 10.1007/s13402-024-00923-z.

Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies.

Bahar M, Kim H, Kim D Signal Transduct Target Ther. 2023; 8(1):455.

PMID: 38105263 PMC: 10725898. DOI: 10.1038/s41392-023-01705-z.

On the Therapeutic Potential of ERK4 in Triple-Negative Breast Cancer.

Boudghene-Stambouli F, Soulez M, Ronkina N, Dorrie A, Kotlyarov A, Seternes O Cancers (Basel). 2023; 15(1).

PMID: 36612022 PMC: 9817496. DOI: 10.3390/cancers15010025.

References

Turgeon B, Saba-El-Leil M, Meloche S . Cloning and characterization of mouse extracellular-signal-regulated protein kinase 3 as a unique gene product of 100 kDa. Biochem J. 2000; 346 Pt 1:169-75. PMC: 1220837. View

Saharinen P, Takaluoma K, Silvennoinen O . Regulation of the Jak2 tyrosine kinase by its pseudokinase domain. Mol Cell Biol. 2000; 20(10):3387-95. PMC: 85631. DOI: 10.1128/MCB.20.10.3387-3395.2000. View

Neininger A, Thielemann H, Gaestel M . FRET-based detection of different conformations of MK2. EMBO Rep. 2001; 2(8):703-8. PMC: 1083994. DOI: 10.1093/embo-reports/kve157. View

Herzig U, Cadenas C, Sieckmann F, Sierralta W, Thaller C, Visel A . Development of high-throughput tools to unravel the complexity of gene expression patterns in the mammalian brain. Novartis Found Symp. 2001; 239:129-46; discussion 146-59. DOI: 10.1002/0470846674.ch11. View

Abe M, Saelzler M, Espinosa 3rd R, Kahle K, Hershenson M, Le Beau M . ERK8, a new member of the mitogen-activated protein kinase family. J Biol Chem. 2002; 277(19):16733-43. DOI: 10.1074/jbc.M112483200. View

Seternes O, Johansen B, Hegge B, Johannessen M, Keyse S, Moens U . Both binding and activation of p38 mitogen-activated protein kinase (MAPK) play essential roles in regulation of the nucleocytoplasmic distribution of MAPK-activated protein kinase 5 by cellular stress. Mol Cell Biol. 2002; 22(20):6931-45. PMC: 139805. DOI: 10.1128/MCB.22.20.6931-6945.2002. View

Johnson G, Lapadat R . Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002; 298(5600):1911-2. DOI: 10.1126/science.1072682. View

Manning G, Whyte D, Martinez R, Hunter T, Sudarsanam S . The protein kinase complement of the human genome. Science. 2002; 298(5600):1912-34. DOI: 10.1126/science.1075762. View

Marchler-Bauer A, Anderson J, DeWeese-Scott C, Fedorova N, Geer L, He S . CDD: a curated Entrez database of conserved domain alignments. Nucleic Acids Res. 2003; 31(1):383-7. PMC: 165534. DOI: 10.1093/nar/gkg087. View

10.

Tanoue T, Nishida E . Molecular recognitions in the MAP kinase cascades. Cell Signal. 2003; 15(5):455-62. DOI: 10.1016/s0898-6568(02)00112-2. View

11.

Underwood K, Parris K, Federico E, Mosyak L, Czerwinski R, Shane T . Catalytically active MAP KAP kinase 2 structures in complex with staurosporine and ADP reveal differences with the autoinhibited enzyme. Structure. 2003; 11(6):627-36. DOI: 10.1016/s0969-2126(03)00092-3. View

12.

Baas A, Boudeau J, Sapkota G, Smit L, Medema R, Morrice N . Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. EMBO J. 2003; 22(12):3062-72. PMC: 162144. DOI: 10.1093/emboj/cdg292. View

13.

New L, Jiang Y, Han J . Regulation of PRAK subcellular location by p38 MAP kinases. Mol Biol Cell. 2003; 14(6):2603-16. PMC: 194907. DOI: 10.1091/mbc.e02-08-0538. View

14.

Coulombe P, Rodier G, Pelletier S, Pellerin J, Meloche S . Rapid turnover of extracellular signal-regulated kinase 3 by the ubiquitin-proteasome pathway defines a novel paradigm of mitogen-activated protein kinase regulation during cellular differentiation. Mol Cell Biol. 2003; 23(13):4542-58. PMC: 164847. DOI: 10.1128/MCB.23.13.4542-4558.2003. View

15.

Boudeau J, Baas A, Deak M, Morrice N, Kieloch A, Schutkowski M . MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm. EMBO J. 2003; 22(19):5102-14. PMC: 204473. DOI: 10.1093/emboj/cdg490. View

16.

Shi Y, Kotlyarov A, Laabeta K, Gruber A, Butt E, Marcus K . Elimination of protein kinase MK5/PRAK activity by targeted homologous recombination. Mol Cell Biol. 2003; 23(21):7732-41. PMC: 207624. DOI: 10.1128/MCB.23.21.7732-7741.2003. View

17.

Julien C, Coulombe P, Meloche S . Nuclear export of ERK3 by a CRM1-dependent mechanism regulates its inhibitory action on cell cycle progression. J Biol Chem. 2003; 278(43):42615-24. DOI: 10.1074/jbc.M302724200. View

18.

Papa F, Zhang C, Shokat K, Walter P . Bypassing a kinase activity with an ATP-competitive drug. Science. 2003; 302(5650):1533-7. DOI: 10.1126/science.1090031. View

19.

Baas A, Kuipers J, van der Wel N, Batlle E, Koerten H, Peters P . Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD. Cell. 2004; 116(3):457-66. DOI: 10.1016/s0092-8674(04)00114-x. View

20.

Roux P, Blenis J . ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev. 2004; 68(2):320-44. PMC: 419926. DOI: 10.1128/MMBR.68.2.320-344.2004. View